FDAFDA · Food and drugs·Recall number D-0218-2017
Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02
Published December 28, 2016 · Recall initiated: August 4, 2016
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- BUPIVACAINE HYDROCHLORIDE
- Manufacturer
- Hospira Inc., A Pfizer Company
- Distributor
- Nationwide
- Lot
- Lot # 59064DK, Exp. 11/17
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.